" class="no-js "lang="en-US"> Bio-Rad Laboratories - Medtech Alert
Thursday, March 28, 2024
Bio-Rad Laboratories | Pharmtech Focus

Bio-Rad Laboratories

About Bio-Rad Laboratories

Bio-Rad Laboratories

Since Bio-Rad was founded over six decades ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, helping people live longer, healthier lives.

Related Story

Bio-Rad Introduces Anti-Evolocumab Antibodies for Use in Preclinical and Clinical Drug Development

August 26 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]

Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring

July 14 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]

Bio-Rad Introduces CFX Opus Deepwell Real-Time PCR Detection System

June 28 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]

Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022

June 7 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]

Bio-Rad Launches CFX Duet Real-Time PCR System

May 27 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]

Bio-Rad Introduces Anti-Cemiplimab Antibodies

April 12 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]

Bio-Rad Introduces Anti-Daratumumab Antibodies

February 15 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]

Bio-Rad Introduces Bio-Plex Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays to Quickly Measure Neutralizing Antibodies Against SARS-CoV-2 Virus

December 20 2021

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]

Bio-Rad Launches its CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics

October 22 2021

Bio–Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic […]

Bio-Rad Launches IgA and IgM SARS-CoV-2 Bio-Plex Pro Immunoassay Panels to Study COVID-19 Antibody Response

October 1 2021

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]